A Safety, Tolerability, and Pharmacokinetics Study of AP303 in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a single-center, randomized, double-blind, placebo-controlled, first-in-human study in which the safety, tolerability, and pharmacokinetics of orally administered AP303 will be assessed in healthy adult subjects.
Epistemonikos ID: 65cab19f516884f40275a32cb408f49bb89c13f6
First added on: May 13, 2024